Versant Capital Management »

Ocular Therapeutix shares owned by Versant Capital Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0k 230 8.54
2024-09-30 $2.0k 230 8.70

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Vanguard Total Stk Mkt Etf (VTI)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Exxon Mobil Corp Stock (XOM)
Apple Stock (AAPL)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)

View all positions for Versant Capital Management

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
venBio Select Advisor
TCG Crossover Management
Opaleye Management
Citadel Advisors
Adage Capital Partners GP
Logos Global Management
State Street Corporation
Perceptive Advisors
Geode Capital Management
Deltec Asset Management

View all funds holding Ocular Therapeutix